Leonard Capital Management’s Syneron Medical Ltd ELOS Stock Holding History

Leonard Capital Management’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-277,000	Closed	-$2.94M	–	99
2015 Q2	$2.94M	Hold	277,000	–	–	1.02%	38
2015 Q1	$3.43M	Buy	277,000 +104,891	+61%	+$1.16M	1.18%	31
2014 Q4	$1.61M	Buy	172,109 +40,000	+30%	+$386K	0.42%	104
2014 Q3	$1.32M	Buy	132,109 +20,000	+18%	+$203K	0.49%	94
2014 Q2	$1.16M	Hold	112,109	–	–	0.39%	105
2014 Q1	$1.4M	Hold	112,109	–	–	0.5%	96
2013 Q4	$1.38M	Hold	112,109	–	–	0.54%	87
2013 Q3	$966K	Hold	112,109	–	–	0.38%	101
2013 Q2	$975K	Buy	+112,109	New	+$1M	0.37%	104

Other funds holding ELOS

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DGHMC

Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Leonard Capital Management's ELOS Position: Q3 2015 in Review

Leonard Capital Management sold out of Syneron Medical Ltd (ELOS) in Q3 2015, closing a stake of 277,000 shares — an estimated $2.94M sold.

Leonard Capital Management first reported a position in ELOS in Q2 2013 and held it in 9 quarters. The position peaked at $3.43M in Q1 2015. 66 funds tracked by Wall St. Rank hold ELOS as of Q3 2015.

Leonard Capital Management reported no remaining Syneron Medical Ltd position as of Q3 2015 after selling out during the quarter.
Leonard Capital Management sold 277,000 Syneron Medical Ltd shares in Q3 2015, an estimated $2.94M.
Leonard Capital Management first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 9 quarters.
Leonard Capital Management's Syneron Medical Ltd position peaked at $3.43M in Q1 2015.
66 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2015.

Based on Leonard Capital Management's 13F filing for Q3 2015.